- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MR perfusion measures coronary stenoses
Quantitative myocardial first-pass perfusion can distinguish coronary artery stenoses with a high degree of specificity and negative predictive value. The test offers an alternative to diagnostic catheterization to grade the severity of coronary artery disease, according to a presentation at the North American Society of Cardiac Imaging meeting.
Quantitative myocardial first-pass perfusion can distinguish coronary artery stenoses with a high degree of specificity and negative predictive value. The test offers an alternative to diagnostic catheterization to grade the severity of coronary artery disease, according to a presentation at the North American Society of Cardiac Imaging meeting.
Dr. Prasad M. Panse and colleagues at the University of Florida at Jacksonville studied 41 patients who underwent catheter angiography and MR first-pass perfusion. The sensitivity, specificity, PPV, and NPV for MR imaging to detect severe stenosis as determined visually from coronary angiograms were 67.6%, 90.1%, 56.5%, and 94.5%, respectively, for each sector. The low per-sector sensitivity was likely the result of microvascular disease, small-vessel disease in diabetic patients, subendocardial ischemia, or other cardiac risk factors. On a per-patient basis, sensitivity rose to 92%.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
